<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00131872</url>
  </required_header>
  <id_info>
    <org_study_id>00168</org_study_id>
    <nct_id>NCT00131872</nct_id>
  </id_info>
  <brief_title>Study to Evaluate the Performance and Safety of Expedial and Compare it to Expanded Polytetrafluoroethylene (ePTFE) Vascular Access Grafts</brief_title>
  <official_title>Clinical Study Comparing Expedial and ePTFE Vascular Access Grafts</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>LeMaitre Vascular</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>LeMaitre Vascular</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to establish the substantial equivalence of Expedial and ePTFE
      grafts for effectiveness in maintaining primary or assisted primary patency.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <start_date>March 2004</start_date>
  <completion_date type="Actual">November 2006</completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Primary or assisted primary patency at 1 year</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Secondary patency</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall adverse event rate</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to first access</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to hemostasis following needle withdrawal after dialysis</measure>
  </secondary_outcome>
  <enrollment>172</enrollment>
  <condition>End Stage Renal Disease</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Expedial Vascular Access Graft</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient has chronic renal failure and requires vascular access for hemodialysis

          -  Patient has given informed consent to participate in the trial and is willing to
             comply with the study protocol

          -  Patient is male or female, 18 years of age or older

          -  The vascular access graft can be placed in the upper extremity (forearm, including
             across the elbow, or upper arm)

          -  Patient is undergoing or will undergo hemodialysis at a hospital or hemodialysis
             center

          -  Patient has a vein 4 mm or larger to which the graft can be anastomosed

        Exclusion Criteria:

          -  Patient is unable to comply with the study follow-up

          -  Patient has a known sensitivity to polyurethane or porcine heparin

          -  Patient has a previous vascular access graft implanted and it is not possible to place
             the study graft proximal to the existing device and no other sites are available

          -  Patient has an immunodeficiency syndrome

          -  Patient has a prior history of bacterial infection within 8 weeks of implantation of
             graft

          -  Patient has a severe coagulation disorder

          -  Patient has an elevated platelet count of greater than 1 million

          -  Patient has a history of heparin-induced thrombocytopenia syndrome (HIT)

          -  Patient is pregnant

          -  Patient has a fever greater than 100 degrees Fahrenheit
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Vascular and General Surgery</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33125</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vascular Surgery Associates</name>
      <address>
        <city>Baton Rouge</city>
        <state>Louisiana</state>
        <zip>70809</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Montefiore Medical Center</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10461</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vascular Surgery</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10461</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>General Surgery</name>
      <address>
        <city>Bamberg</city>
        <state>South Carolina</state>
        <zip>29003</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>South Carolina Associates for Cardiac and Vascular Disease; Greenville Hospital System</name>
      <address>
        <city>Greenville</city>
        <state>South Carolina</state>
        <zip>29605</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Peripheral Vascular Associates</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78206</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2006</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 17, 2005</study_first_submitted>
  <study_first_submitted_qc>August 18, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 19, 2005</study_first_posted>
  <last_update_submitted>January 24, 2008</last_update_submitted>
  <last_update_submitted_qc>January 24, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 29, 2008</last_update_posted>
  <keyword>vascular access graft</keyword>
  <keyword>hemodialysis</keyword>
  <keyword>dialysis</keyword>
  <keyword>end stage renal disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Kidney Failure, Chronic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

